Health Condition 1: null- Diabetic Nephropathy with concomitant Hypertension
Conditions
Interventions
Intervention1: Angiotensin Converting Enzyme Inhibitor - RAMIPRIL
: RAMIPRIL 5mg orally OD for 3 months
Control Intervention1: Angiotensin Receptor Blocker - TELMISARTAN: TELMISARTAN 40mg orally OD fo
Sponsors
Sowmya Bondalapati
Eligibility
Inclusion criteria
Inclusion criteria: • All IP/OP diagnosed with Type II DM with concomitant mild to moderate hypertension associated with albuminuria detected by dip stick method. • DN patients either on Insulin / Oral hypoglycemics.
Exclusion criteria
Exclusion criteria: • Age 30 and 65 years of either sex • Patients diagnosed with Type I DM/ IDDM • Patients with severe hypertension. • Patients with proteinuria who are on dialysis/ renal transplant • Patients with H/O concomitant illness: TB/ CHF/ BA/ Epilepsy/ Ascites. • Pregnant / lactating women • Patients with H/O of other causes of proteinuria like analgesic nephropathy, nephrolithiasis, renal malignancies, metastasis to kidney, UTI, SLE, PKD.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Urine ALBUMINTimepoint: Baseline visit, 4 weeks, 8 weeks, 12 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in spot PCR and Glycosylated Hb levelsTimepoint: Baseline visit, 4 weeks, 8 weeks, 12 weeks. | — |
Countries
India
Contacts
Public ContactSowmya Bondalapati
MAMATA MEDICAL COLLEGE and HOSPITAL affiliated to NTR University of Health Sciences
Outcome results
None listed